000 | 00994 a2200289 4500 | ||
---|---|---|---|
005 | 20250516015536.0 | ||
264 | 0 | _c20110121 | |
008 | 201101s 0 0 eng d | ||
022 | _a1469-8749 | ||
024 | 7 |
_a10.1111/j.1469-8749.2010.03804.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aO'Hare, Anne | |
245 | 0 | 0 |
_aGrappling with the grey evidence. _h[electronic resource] |
260 |
_bDevelopmental medicine and child neurology _cNov 2010 |
||
300 |
_a979 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aChild Development Disorders, Pervasive _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy, Active _xadverse effects |
650 | 0 | 4 | _aMeasles |
650 | 0 | 4 | _aMumps |
650 | 0 | 4 |
_aRNA Virus Infections _ximmunology |
650 | 0 | 4 | _aRubella |
773 | 0 |
_tDevelopmental medicine and child neurology _gvol. 52 _gno. 11 _gp. 979 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1469-8749.2010.03804.x _zAvailable from publisher's website |
999 |
_c20463581 _d20463581 |